As recently suggested [32], therapies targeting SC niche restoration or targeting of specific factors/pathways to improve muscle regeneration should be investigated in FSHD in combination with DUX4 suppression. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.